Legal entity
regulation is the sole category represented across all 1 tracked stories. Justice Sachin Datta is most often covered alongside Central Drugs Standard Control Organisation (CDSCO), which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window.
Last mentioned: Mar 18, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Justice Sachin Datta is most often covered alongside Central Drugs Standard Control Organisation (CDSCO), which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window. At 6, the average consequence score sits below the same-window beat average of 6.1. We currently track 1 Legal story that mention Justice Sachin Datta, all published on March 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 56 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Justice Sachin Datta. Shared-story counts are live from our verified record — not editorial picks.
Expected Response
Deadline for CDSCO to justify the delay in regulatory action (Estimated).
Contempt Petition Filed
Petitioners allege CDSCO failed to act on the court's previous safety mandate.
Notice Issued
Justice Sachin Datta issues formal contempt notice seeking a response from the CDSCO.
Initial Judicial Order
Delhi HC directs CDSCO to examine the safety of diabetes drugs used for weight management.
The Delhi High Court has initiated contempt proceedings against India's top drug regulator, the CDSCO, for failing to act on a judicial mandate to evaluate the safety of diabetes medications used off-label for weight loss. This escalation highlights growing judicial impatience with regulatory inertia regarding the global surge in GLP-1 receptor agonist use.
Source: Yes Punjab News · prokerala.com
Justice Sachin Datta is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
